Siddharth Shanbhag

Dr. Siddharth Shanbhag


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2012 in Journal of Clinical Periodontology
Verified
Journal Article
Closed access
PDF file
SSSiddharth Shanbhag
Siddharth Shanbhag
MDManu Dahiya
Manu Dahiya
RCRay Croucher
Ray Croucher

1 July 2013 in Journal of Endodontics
Verified
Journal Article
Closed access
SSSiddharth Shanbhag
Siddharth Shanbhag
PKPrabodh Karnik
Prabodh Karnik
PSPrashant Shirke
Prashant Shirke
VSVivek Shanbhag
Vivek Shanbhag

1 July 2014 in The International Journal of Oral and Maxillofacial Implants
Verified
Journal Article
Closed access
SSSiddharth Shanbhag
Siddharth Shanbhag
VSVivek Shanbhag
Vivek Shanbhag
ASAndreas Stavropoulos
Andreas Stavropoulos
Siddharth Shanbhag, BDS, MSc/Vivek Shanbhag, BDS, MDS/Andreas Stavropoulos, DDS, PhD, Odont Dr: Purpose: The objective of this study was to systematically review the available literature on three-dimensional time-dependent graft volume changes after sinus augmentation (SA) with different biomaterials in humans. Materials and Methods: MEDLINE, EMBASE, and CENTRAL were searched for related literature. Controlled and uncontrolled studies reporting volume changes of more than 10 SAs after at least 6 months, assessed by computed tomography (CT) or cone beam CT (CBCT), were eligible for inclusion. The primary outcome of interest was time-dependent percentage change in augmentation volume. Results: Seven controlled and five uncontrolled studies (n = 234 SAs) with a high risk of bias were included and reported on a range of graft materials. Autogenous bone (AB) was used in the particulate or block form. Bone substitutes (BS) were used either alone or in combination with other materials as composite grafts (CG). All studies reported reductions in augmentation volumes over time (AVR), generally after short observation periods (range, 6 months to 6 years). Substantial AVRs (approximately 45% in 77 SAs) were reported for AB after 6 months and up to 2 years. AVRs for solely BS or CG were relatively lower (approximately 18% to 22% in 142 SAs) after a similar time period. All studies reported a wide range of volume reductions. No significant differences in AVR were observed between different graft materials. Because of insufficient long-term data, a reliable association between volume reduction and time could not be established. Conclusion: Some loss of augmentation volume always occurs after SA during early healing times. In general, less AVR may be expected after SA with BS or CG compared to SA with AB. Augmentation volume loss does not seem to compromise implant placement or survival.

8 April 2013 in Clinical Oral Implants Research
Verified
Journal Article
Closed access
PDF file
SSSiddharth Shanbhag
Siddharth Shanbhag
PKPrabodh Karnik
Prabodh Karnik
PSPrashant Shirke
Prashant Shirke
VSVivek Shanbhag
Vivek Shanbhag

9 January 2019 in Journal of Clinical Periodontology
Verified
Journal Article
Closed access
PDF file
SSSiddharth Shanbhag
Siddharth Shanbhag
SSSalwa Suliman
Salwa Suliman
NPNikolaos Pandis
Nikolaos Pandis
ASAndreas Stavropoulos
Andreas Stavropoulos
Mariano SanzMariano Sanz
Mariano Sanz
KMKamal Mustafa
Kamal Mustafa

14 November 2021 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
SSSiddharth Shanbhag
Siddharth Shanbhag
SSSalwa Suliman
Salwa Suliman
SMSamih Mohamed-Ahmed
Samih Mohamed-Ahmed
CKCarina Kampleitner
Carina Kampleitner
MHMohamed Nageeb Hassan
Mohamed Nageeb Hassan
KMKamal Mustafa
Kamal Mustafa
Background: Three-dimensional (3D) spheroid culture can promote the osteogenic differentiation of bone marrow mesenchymal stromal cells (BMSC). 3D printing offers the possibility to produce customized scaffolds for complex bone defects. The aim of this study was to compare the potential of human BMSC cultured as 2D monolayers or 3D spheroids encapsulated in constructs of 3D-printed poly-L-lactide-co-trimethylene carbonate scaffolds and modified human platelet lysate hydrogels (PLATMC-HPLG) for bone regeneration. Methods: PLATMC-HPLG constructs with 2D or 3D BMSC were assessed for osteogenic differentiation based on gene expression and in vitro mineralization. Subsequently, PLATMC-HPLG constructs with 2D or 3D BMSC were implanted in rat calvarial defects for 12 weeks; cell-free constructs served as controls. Bone regeneration was assessed via in vivo computed tomography (CT), ex vivo micro-CT and histology. Results: Osteogenic gene expression was significantly enhanced in 3D versus 2D BMSC prior to, but not after, encapsulation in PLATMC-HPLG constructs. A trend for greater in vitro mineralization was observed in constructs with 3D versus 2D BMSC (p > 0.05). In vivo CT revealed comparable bone formation after 4, 8 and 12 weeks in all groups. After 12 weeks, micro-CT revealed substantial regeneration in 2D BMSC (62.47 ± 19.46%), 3D BMSC (51.01 ± 24.43%) and cell-free PLATMC-HPLG constructs (43.20 ± 30.09%) (p > 0.05). A similar trend was observed in the histological analysis. Conclusion: Despite a trend for superior in vitro mineralization, constructs with 3D and 2D BMSC performed similarly in vivo. Regardless of monolayer or spheroid cell culture, PLATMC-HPLG constructs represent promising scaffolds for bone tissue engineering applications.